Insider Trading
Slightly above 67% of Talis Biomedical's investor base is looking to short. The analysis of overall sentiment of trading Talis Biomedical Corp pink sheet suggests that many investors are alarmed at this time. Talis Biomedical's investing sentiment can be driven by a variety of factors including economic data, Talis Biomedical's earnings reports, geopolitical events, and overall market trends.
Talis Biomedical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Talis daily returns and investor perception about the current price of Talis Biomedical Corp as well as its diversification or hedging effects on your existing portfolios.
Talis |
Filed transaction by Talis Biomedical Corp Director: . Insider Public Trading
Read at macroaxis.com
Talis Biomedical Fundamental Analysis
We analyze Talis Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talis Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talis Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Talis Biomedical is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Talis Biomedical Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talis Biomedical pink sheet to make a market-neutral strategy. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics with similar companies.
Peers
Talis Biomedical Related Equities
BJDX | Bluejay Diagnostics | 10.59 | ||||
BVS | Bioventus | 4.21 | ||||
NPCE | Neuropace | 3.11 | ||||
NUWE | Nuwellis | 2.46 | ||||
SGHT | Sight Sciences | 0.38 | ||||
HSCS | Heart Test | 0.84 | ||||
SSKN | STRATA Skin | 1.12 | ||||
TNON | Tenon Medical | 3.60 | ||||
BBLG | Bone Biologics | 5.32 | ||||
TIVC | Tivic Health | 10.00 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |